CELU
Celularity·NASDAQ
--
--(--)
--
--(--)
3.67 / 10
Netural
Analyst coverage is limited to one Strong Buy, but its historical win rate is 0% and average return –23.4%, indicating low reliability. Fund‑flow score is 7.34/10, with small and medium investors net inflowing despite overall negative trends. Liquidity remains decent.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Steve BrozakStrong Buy
Date2025-09-09
InstitutionWBB Securities
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for CELU?
- CELU holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.67/10 (Netural).
